About iShares U.S. Pharmaceuticals ETF (IHE)

The iShares U.S. Pharmaceuticals ETF (IHE) is an exchange-traded fund that seeks to track the investment results of an index composed of U.S. equities in the pharmaceutical sector. With a focus on companies involved in the research, development, and production of pharmaceutical drugs, IHE provides investors with exposure to this specific industry. By investing in IHE, investors can gain access to a diverse portfolio of pharmaceutical companies, which may include both large-cap and mid-cap stocks. This ETF aims to replicate the performance of the Dow Jones U.S. Select Pharmaceuticals Index, which represents the pharmaceutical subsector of the broader U.S. stock market.

As of the latest quote, the iShares U.S. Pharmaceuticals ETF (IHE) has a market price of $173.62 per share. This price represents the current value at which investors can buy or sell shares of IHE on the open market. Please note that the market price may fluctuate throughout the trading day as investors buy and sell ETF shares. It's important to keep track of the latest market price if you are considering investing in IHE. The historical price chart of IHE shows the price performance of the ETF over time, allowing investors to assess its past performance and make informed investment decisions.